Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Repetitive Behaviors in Mental Retardation
NCT00491478Phase 3Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Sep 1992
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sertraline in stereotypic movement disorder (SMD), Self-injurious behavior and obsessive compulsive disorder (OCD), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Status: unknown.
02
Drugs
sertraline
03
Conditions
stereotypic movement disorder (SMD)Self-injurious behaviorobsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00491478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491478.